|
Try for FREE
Download and test drive MovAlyzeR® for 15 days.
|
|
|
Order Now
Purchase MovAlyzeR® from our online store.
|
|
|
|
What cannot be detected with conventional methods...
Specific psychotropic medications at higher dosages cause movement side effects in some patients. Psychiatrists evaluate
these movement side-effects using clinical rating scales: Simpson Angus Scale for Extrapyramidal Symptoms (EPS) and
parkinsonism (SAEPS or SAS), Abnormal Involuntary Movement Scale for tardive dyskinesia (AIMS), and Barnes Akathisia Rating
Scale for restlessness (BARS or BAS).
|
|
Since chronic EPS can lead to tardive dyskinesia, proper monitoring of these side-effects can reduce the risk for patients.
However, until now, there has been no objective test that can identify movement side-effects from medication.
|
|
|
...can be detected in kinematic handwriting analysis.
Research has shown that, where clinical rating scales do not detect movement side-effects, the handwriting kinematic measures
of NeuroScript's MovAlyzeR® software do show medication and dosage effects (Patent pending WO2008143978).
|
|
|
Psychiatrists, nurses and general physicians can identify EPS manifestations: Tremor, stiffness, slow movements and restlessness (akathisia).
Movement data provide objective documentation on the absence of medication side effects or on the decisions to alter medication. While FDA
approval is pending, this system can be used for research.
Supported by the US National Institutes of Mental Health (NIMH) grant “Movement Analysis to Monitor Medication Side Effects” (2R44MH073192).
|
|
Video Demonstrations of MovAlyzeR® Example Tests and Features
Example Test: PH2. Measuring movement side effects (e.g., EPS) due to medication.
H.J. Haase and P.A.J. Janssen, The Action of Neuroleptic Drugs, Year Book Medical Publishers, Chicago (1965)